A Dual-specificity Isoform of the Protein Kinase Inhibitor PKI Produced by Alternate Gene Splicing
Overview
Authors
Affiliations
We have previously shown that the protein kinase inhibitor beta (PKIbeta) form of the cAMP-dependent protein kinase inhibitor exists in multiple isoforms, some of which are specific inhibitors of the cAMP-dependent protein kinase, whereas others also inhibit the cGMP-dependent enzyme [Kumar, Van Patten and Walsh (1997), J. Biol. Chem. 272, 20011-20020]. We have now demonstrated that the switch from a cAMP-dependent protein kinase (PKA)-specific inhibitor to one with dual specificity arises as a consequence of alternate gene splicing. We have confirmed using bacterially produced pure protein that a single inhibitor species has dual specificity for both PKA and cGMP-dependent protein kinase (PKG), inhibiting each with very high and closely similar inhibitory potencies. The gene splicing converted a protein with 70 amino acids into one of 109 amino acids, and did not change the inhibitory potency to PKA, but changed it from a protein that had no detectable PKG inhibitory activity to one that now inhibited PKG in the nanomolar range.
MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages.
Ghorpade D, Leyland R, Kurowska-Stolarska M, Patil S, Balaji K Mol Cell Biol. 2012; 32(12):2239-53.
PMID: 22473996 PMC: 3372268. DOI: 10.1128/MCB.06597-11.
Huang H, Turner D, Thompson R, Uhler M J Neurochem. 2011; 120(5):667-83.
PMID: 21623794 PMC: 3363362. DOI: 10.1111/j.1471-4159.2011.07332.x.
Lavogina D, Nickl C, Enkvist E, Raidaru G, Lust M, Vaasa A Biochim Biophys Acta. 2010; 1804(9):1857-68.
PMID: 20406699 PMC: 3071016. DOI: 10.1016/j.bbapap.2010.04.007.
Ng S, Yoshida T, Zhang J, Georgopoulos K Immunity. 2009; 30(4):493-507.
PMID: 19345118 PMC: 3012962. DOI: 10.1016/j.immuni.2009.01.014.